Its going to be a huge merger run on DUSS . 302M shares in
Its going to be a huge merger run on DUSS . 302M shares in float. not further dilution. OTCBB Triple Zero stock with a healthy chart and as per PR from this week, a merger or JV coming by end of January. DUSS is being accumulated by many of us. Join us on the bid there at 0.0006 or slap 7s to ensure you have what you need before we take it to 0.005+. There are many longs who are holding for much higher prices and we have been weeding out the flippers nicely.
High Alert found on website with Merger Excitement that is building exponentially. Check it out. Folks are spreading the word on $DUSS like wildfire !
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Rocket Lab's Recent Stock Surge Shares of Rocket Lab Corp (NASDAQ: RKLB) have hit a remarkable all-time high, showcasing the company's increasing prominence in the space launch industry. This unprecedented rise in stock value can be largely attributed to a series of lucrative contracts that have instilled confidence among investors. Positive Developments Fueling Investor...
Continue Reading
Michaels Expands Offerings with The Knit & Sew Shop and The Party Shop Michaels continues to be a prominent name in North America by introducing exciting new store-in-store experiences known as The Knit & Sew Shop and The Party Shop. This strategic move not only enriches the shopping experience for customers, but also reinforces Michaels' position as the largest specialty...
Continue Reading
Liberty Hill Foundation Expands Leadership Team As Liberty Hill Foundation marks an important milestone, it has made significant changes to its executive leadership to bolster its efforts in supporting grassroots organizations in Los Angeles. This transformation is aimed at ensuring long-term sustainability and societal impact during a crucial time in history. New...
Continue Reading
GSK plc Shares Encouraging Results on Combined RSV and Shingles Vaccines GSK plc (LSE/NYSE: GSK) has just announced encouraging topline findings from an important phase 3 trial involving adults aged 50 and older. This study assessed the immunogenicity, reactogenicity, and safety of AREXVY, a vaccine for respiratory syncytial virus (RSV), when given together with SHINGRIX,...
Continue Reading
Investors Should Take Action Regarding Hasbro, Inc. Attention investors! A recent announcement has surfaced indicating a class action lawsuit against Hasbro, Inc. This legal action is initiated by Bronstein, Gewirtz & Grossman, LLC, a well-known law firm in the field of securities fraud. The firm aims to represent those individuals and entities that may have suffered...
Continue Reading
